The thermal denaturation of poliovirus virions and procapsids in the 42 to 48 °C range was studied using N-and H-specific monocional antibodies. The half-life of the N antigen of Mahoney and Sabin 1 virions was extended 50-to 250-fold by either 10 ~tM WIN 51711 or R 78206. The minimum concentrations required for full stabilization at 46 °C (1-0 ~tM for WIN 51711, 0-2 g~,l for R 78206) were independent of the strain or serotype of the virus; 30 to 60 molecules of stabilizer per virion were required for full protection. R 78206 was the most efficient stabilizer of Mahoney procapsids; the half-life of the N-specific epitopes of these particles at 44 *C was extended from less than 1 min to 1 day.
Introduction
A number of structurally unrelated compounds are known to exert an anti-picornavirus activity by direct interaction with the virions. Among these are flavans and chalcones (Bauer et al., 1981 ; Ishitsuka et al., 1982) , as well as several pyridines (Kenny et al., 1986) , isoxazoles (the WIN compounds; Otto et al., 1985) , and pyridazinamines (Andries et al., 1988) . In rhinoviruses, several WIN compounds and R 61837, the prototype of the pyridazinamine derivatives, have been shown to bind into a hydrophobic pocket located at the base of the 'canyon', within the fl-barrel of capsid protein VP1 (Smith et al., 1986; Chapman et al., 1991) . Antipicornavirus compounds generally stabilize susceptible serotypes of rhino-, echo-and polioviruses against inactivation by heat, or by acid or alkaline pH (reviewed by Andries et al., 1989) ; in particular, WIN 51711 increases the immunogenicity of polio virions in mice and stabilizes procapsids up to 42 °C (Rombaut et al., 1990b) .
In terms of poliovirus vaccines, heat stabilization might be useful in two respects: to reduce the need for an unbroken cold chain with oral live attenuated vaccines, and to permit the use of thermolabile antigens in parenteral inactivated vaccine preparations. In the present work, two unrelated compounds, the isoxazole WIN 51711 and pyridazinamine R 78206 ( Fig. 1) , with high anti-poliovirus activities in vitro (Table 1) were tested for their ability to prevent thermal denaturation of otherwise unprotected virions and procapsids.
(a)
/0 /~kO Stabilizing compounds. WIN 51711 (5-[7-[4(4,5-dihydro-2-oxazolyl Stock solutions of both compounds (10 mg/ml) were made in dimethyl sulphoxide and diluted in NET buffer (150 mM-NaCI, 5 mM-EDTA, 50 mM-Tris-HCl pH 7.2) before use.
Virus purification. Purification of radiolabelled virions was essentially as described by Rombaut et al. (1990b) . Briefly, HeLa cells in suspension were infected with poliovirus (strain to be specified) at an input multiplicity of 100 p.f.u, per cell. [35S]Methionine was added from 3 to 6 h p.i. Cells were collected and extracted after three cycles of freezing and thawing and the viral material was pelleted by centrifugation after clarification of the radiolabelled extract by a short centrifugation and blending with butanol. Finally, the pellet was resuspended in NET buffer and submitted to sucrose gradient ultracentrifugation. The 160S material was collected and kept at -80 °C. The same method was used for the preparation of unlabelled virions, except that no radiolabelled methionine was added.
The concentration of virions was determined as described by Everaert et al. (1989) , 1 p.f.u, corresponds to approximately 200 virions (Everaert et al., 1989) , and a 10 pM suspension to 3 x 107 p.f.u./ml.
Preparation of radiolabelled procapsids. Radiolabelled cell extracts were prepared as described above. After adding 5 gg/ml RNase, the supernatant was incubated for 1 h at 20 °C and submitted to sucrose gradient uttracentrifugation. The 65S procapsids were collected and further purified by high-performance size-exclusion chromatography using two Ultrahydrogel t000 columns (Rombaut et al., 1990c) . The eluate fractions containing the procapsids were pooled and kept at -80 °C. The concentration of procapsids was determined as described in Rombaut et al. (1990c) .
Monoclonal antibodies and Protein A-aided immunoprecipitation.
Four different monoclonal antibodies directed against poliovirus serotype 1 were used. All recognized the Sabin 1 and Mahoney strains equally well. Three antibodies were directed against the main neutralizing sites of poliovirus type 1 (Page et al., 1988; Rombaut et al., 1990 a) : antibody 36-5h2 (site 2), 424 (3A) and 35-2b6 (3B). The fourth antibody, 39-5b4 (Brioen et al., 1982) was non-neutralizing. It recognized H antigen (i.e. virions heated for 20 min at 56 °C), but neither native virions nor procapsids.
Monoclonal antibodies against serotypes 2 and 3 were also used. The antibodies 434 and 1037 were directed against the neutralizing sites 1 and 2 of serotype 2, and 132 and 875 were directed against sites l and 2 of serotype 3, respectively (Minor et al., 1986) .
Protein A-aided micro-immunoprecipitation was as described (Vrijsen et al., 1983) . Briefly, 80 ~tl of antigen was mixed with 10 gl of antibodies, the mixture was allowed to stand for 1 h at 4 °C, and 40 ~tl of a 10~ suspension of formalin-fixed Staphylococcus aureus strain Cowan I was added. After 30 min, the plate was centrifuged for 15 min at 1100 g and a 50 gl sample of the supernatant was removed for radioactivity assay.
Results

Stabilization of poliovirus virions
All stabilization experiments were carried out in Mg 2+-free NET buffer to avoid any interference of Mg 2+, which is itself a stabilizer (Wallis & Melnick, 1961; Rombaut et al., 1985) , with the compounds under Fig. 2 ; as before, the decay curves of the three neutralizing antigenic sites were identical, and the loss of N antigen was always compensated by the gain of H antigen.
t No antigenic conversion after 1 week. :~ No antigenic conversion after 20 h. § Only 30% conversion after 20 h incubation.
investigation. Fully purified virus was used throughout, and the virus concentration was 10 pM, unless stated otherwise.
A 10 pM suspension of radiolabelled Mahoney (type 1) virions was divided into three portions. The first portion received 10 ~IM WIN 51711, the second 10 ~M R 78206, with the third serving as a control. The three portions were incubated simultaneously and samples were collected at various times for the determination of N-and Hantigenic particles. Fig. 2 shows the results obtained when incubation was at 46 °C. In the control (Fig. 2a) , the N-antigenic particles (characterized by the possession of antigenic sites 2, 3A and 3B) were converted to H antigen with exponential kinetics. The half-life of the unprotected Mahoney strain N antigen was 5 rain. In the presence of 10 ~M WIN 51711 or 10 IXM R 78206, it had increased 50-fold to 4 h ( Fig. 2b, c; Table 2 ). A similar extension (from 30 min to 24 h) was observed at 44 °C (Table 2) .
Experiments were extended to include the Sabin 1 vaccine strain. In agreement with literature data (N akano et al., 1978; Kohara et al., 1985) , the half-life of the unprotected N antigen of Sabin 1 was significantly shorter than that of the Mahoney strain (Table 2) . However, this half-life was extended 250-fold by 10 ~M WIN 51711 or R 78206, slightly exceeding that of the Mahoney strain at 46 °C and 48 °C ( Table 2) .
The concentration dependence of stabilization was tested using 10 pM Mahoney virions in NET buffer, and 30 min at 46 °C as standard conditions. The compounds were added in twofold concentration steps, as shown in Fig. 3 . Full stabilization was achieved with 1.0 ~tM WIN 51711 (Fig. 3a) , or 0.2 gM R78206 (Fig. 3b) , and these Fig. 2 ). The MSC46 is the lowest concentration at which there was less than 5% antigenic conversion.
t Different virus concentrations were used to compensate for the unequal labelling of the four strains so that 103 c.p.m, would be available for each immunoprecipitation test.
concentrations thus represent the minimum stabilizing concentrations at 46 °C (M5C46).
As shown above, the MSC46 for stabilization of Mahoney virions was 1-0 pM with WIN 51711 and 0.2 pM with R 78206. The same results were obtained with the Sabin l, MEF-1 and Leon strains, showing that the stabilization was independent of attenuation and serotype (Table 3 ). The lowest concentrations that protected 509/0 of cells from c.p.e. (MIC values; Andries et al., 1988 Andries et al., , 1990 were higher for WIN 51711 than for R 78206; but there were also significant differences between the four virus strains (Table 1 ).
In the experiments reported above, the stabilizing compounds were in great molar excess over the virus itself. Even at the MSC46, the molarity of the stabilizing compound exceeded that of the virus (10 pM) by a factor of 105 for WIN 51711, or 2 x 104 for R 78206. The question whether stabilization could also be achieved at lower stabilizer/virus ratio was investigated. In these experiments, the concentration of the compounds was kept constant at their MSC46, while the virus concentration was raised stepwise to the highest attainable levels. The mixtures were tested after standard incubations of 30 min at 46 °C. As shown in Table 4 , full stabilization * Virions and WIN 51711 or R 78206 were mixed as stated. After incubation at 46 °C for 30 min, the mixtures were analysed by immunoprecipitation as explained in Fig. 2. ] Percentage radioactivity precipitated by monoclonal antibodies targeted against N or H antigen. * Procapsids were purified as described in Methods. The half-life was determined as in Fig. 2 using Protein A-aided immunoprecipitation with the same set of monoclonal antibodies.
"j" No antigenic conversion after 20 h incubation. Only 40% conversion after 20 h incubation.
was achieved with 60 molecules of WIN 51711 or 30 molecules of R 78206 per virion.
Stabilization of type 1 (Mahoney) procapsids
We reported elsewhere that WIN 51711 protected procapsids against thermal denaturation at temperatures up to 42 °C (Rombaut et al., 1990b) . We repeated the experiments with the following differences: (i) the procapsids were fully purified by the same combination of sucrose gradient ultracentrifugation and highperformance size-exclusion chromatography that was formerly used for the purification of 14S subunits (Rombaut et al., 1990 c) ; (ii) the molarity of the particles, which was unknown in previous work, was now set at 10 pM to allow direct comparison with the experiments on virions reported above; (iii) the buffer was NET (no Mg 2÷) instead of RSB (1.5 mM-MgZ÷), so that the procapsids were now absolutely unprotected. Under these conditions, the half-life of the N epitopes was only 18 min at 37 °C and 2 min at 42 °C (Table 5) . Up to 42°C, both 10 OM WIN 51711 and 10 ~tM R 78206 achieved full stabilization; but from 44°C upward, the two compounds yielded different results. WIN 51711 extended the half-life of N antigen to 15 min at 44 °C, but yielded no measurable stabilization at 46 °C. On the other hand, R 78206 extended the half-life to roughly 1 day at 44 °C and to 4 h at 46 °C.
Discussion
The virion stabilization experiments revealed a great deal of similarity between R 78206 and WIN 51711. With both compounds the half-life of the virions was extended 50-fold for the Mahoney strain, and 250-fold for Sabin 1, and the minimum concentrations and molar ratios required for virion stabilization were similar, with a marginal advantage for R 78206. The concentration dependence of stabilization shown in Fig. 2 probably reflects a small difference between the binding constants of the two compounds to Mahoney strain virions, which was magnified by the high number of bound drug molecules that are presumably required for stabilization (see below); this requirement also probably explains why the transition from sensitivity to stabilization is so steep.
Thirty to 60 stabilizing molecules per virion were required for full protection of Mahoney strain virions, suggesting that a high proportion of the 60 virus pockets needed filling. Similarly, the WIN 51711 stabilization of 14S subunits, which have five pockets, required between seven and 14 molecules (Rombaut & Boey& 1991) .
R 78206 on a molar basis was five to 10 times more efficient than WIN 51711 both as a stabilizer (MSC46 ,  Table 3 ) and as an inhibitor (MIC, Table l). However, whereas the MSC46 values for either compound were similar for all virus strains, the MIC values of the four strains differed greatly, following a different pattern for the two compounds. Thus there was no correlation between the sensitivities of the different strains to the two compounds, or between the MIC and MSC46 values of the individual strains. A similar lack of quantitative correlation between inhibition of replication and thermal stabilization has been reported for the interaction of rhinoviruses with capsid-binding compounds (Andries et al., 1989) , suggesting that factors other than stabilization contribute to the inhibition of replication of both polioviruses and rhinoviruses. The present report illustrates the possible use of antiviral compounds to protect thermolabile antigens in parenteral inactivated vaccine preparations. Additional requirements, such as ready dissociation, must be met if capsid-binding compounds are to be used as stabilizers of oral live attenuated vaccines.
With procapsids, R 78206 scored distinctly better than WIN 51711, as it extended protection from 42 °C to 46 °C. Remarkably, R 78206 ensured similar half-lives at 46 °C of Mahoney strain virions and procapsids which, when unprotected, greatly differ in their stability. That the compounds were able to compensate for these differences may suggest that the stability of the pocket itself plays a major role in the thermostability of the surrounding structures.
The efficient stabilization of procapsids by R 78206 seriously improves the prospect of using these particles as the active ingredient of a polio vaccine (see Rombaut et al., 1990b for a fuller discussion). It remains to be seen whether the effect of WIN 51711 or R 78206 increases in conjunction with other stabilizers such as Mg 2+.
